Lilly to set up new mfg, quality hub in Hyd
It’s part of $1-bn investment lined up for expansion plan in India
Patrik Jonsson, president, Eli Lilly, along with company’s associate V-P Shilpa Gupta, and Eli Lilly India’s president Winselow Tucker, sharing expansion plan details with Telangana CM A Revanth Reddy and IT Minister Sridhar Babu at Secretariat on Monday
Hyderabad: Global biopharmaceutical leader Eli Lilly and Company (Lilly) has announced a major investment of over $1 billion to establish new contract manufacturing operations in India. The investment, spread over the next several years, aims to expand Lilly’s global manufacturing capacity and improve patient access to its portfolio of innovative medicines worldwide.
As part of this expansion, Lilly will also set up a new Manufacturing & Quality hub in Hyderabad, designed to provide advanced technical support and oversight for its contract manufacturing network across India. Recruitment for the new facility will begin immediately, opening opportunities for engineers, chemists, analytical scientists, quality assurance experts, and management professionals.
This strategic move aligns with India’s ‘Make in India’ initiative, reinforcing the country’s growing importance in the global pharmaceutical supply chain. Since 2020, Lilly has invested more than $55 billion globally to build and expand manufacturing facilities, focusing on next-generation medicines addressing diabetes, obesity, Alzheimer’s disease, cancer, and autoimmune disorders.
Telangana Chief Minister A Revanth Reddy welcomed the announcement, stating, “Lilly’s continued expansion in Hyderabad highlights the city’s emergence as a powerhouse in global healthcare innovation. From its Innovation and Technology site to the new Manufacturing & Quality hub, Lilly’s presence reaffirms Telangana’s position as a preferred destination for advanced healthcare investments.”
Telangana Industries Minister D Sridhar Babu added: “Lilly’s investment is a testament to Telangana’s robust industrial ecosystem and technology-driven infrastructure. The state’s focus on ease of doing business continues to attract global healthcare leaders, fueling growth in the life sciences sector.”
